VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to B-cell Lymphoma
Related studies linked through entity extraction aliases.
PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
- Status
- COMPLETED
- Phase
- N/A